Rating History for AstraZeneca (AZN) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/23/2024 | Mark Purcell | New Coverage | Overweight (N/A) |
85.00 (N/A) |
66.54 (68.55) |
3.02% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/23/2024 | Mark Purcell | New Coverage | Overweight (N/A) |
85.00 (N/A) |
66.54 (68.55) |
3.02% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
